Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Therapy for Chronic Cold Agglutinin Disease
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
- Status
- COMPLETED
- Phase
- PHASE4
TBI Dose De-escalation for Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell Vaccination During Lymphoid Reconstruction
- Status
- COMPLETED
- Phase
- PHASE1
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
- Status
- TERMINATED
- Phase
- PHASE1
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Support in Vasculitis
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3